2025 Newsmaker: Jeff Simmons
Jeff Simmons has been CEO of Elanco since its spinoff from Eli Lilly and Co. in 2018, guided the company’s 2020 acquisition of Bayer Animal Health and has overseen the development of drugs that are starting to pay off in profits and investor confidence.